SI
Sentonix, Inc.
SEC filingPharmaceuticals · Arlington, MA
Amount raised$12.7Msold at filing
Total offering$21.2M$8.5M still open
Investors in the raise17count reported to the SEC
FiledAug 20, 2026first sale Aug 13, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Kenan TurnaciogluExecutive Officer, Director
John BeaverExecutive Officer, Director
Karl SchmidtExecutive Officer
Jack HoppinDirector
Executive officers, directors and promoters as listed on the Form D.